Companies

Neumora Therapeutics, Inc. (NMRA) SEC filings

CIK 0001885522 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024
Net income (USD)-235.9 M
Diluted EPS (USD/shares)-1.45-3.63

Latest filings

FiledFormDescriptionPeriod
2026-08-214FORM 42026-08-20
2026-08-214FORM 42026-08-20
2026-08-214FORM 42026-08-20
2026-08-214FORM 42026-08-20
2026-08-214FORM 42026-08-20
2026-08-21144144
2026-08-20144144
2026-08-194FORM 42026-08-17
2026-08-19144144
2026-08-18144144
2026-08-17144144
2026-08-1410-Q10-Q2026-06-30
2026-08-148-K8-K items 2.02,5.02,9.012026-08-14
2026-07-278-K8-K items 8.01,9.012026-07-27
2026-06-158-K8-K items 1.01,2.03,2.05,7.01,8.01,9.012026-06-10
2026-05-29442026-05-27
2026-05-29442026-05-27
2026-05-29442026-05-27
2026-05-29442026-05-27
2026-05-29442026-05-27
2026-05-298-K8-K items 5.072026-05-27
2026-05-15SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-0710-Q10-Q2026-03-31
2026-05-078-K8-K items 2.02,9.012026-05-07
2026-05-04SCHEDULE 13G/ASCHEDULE 13G/A

Forms on file (last 1,000): 4 101, 8-K 31, 144 26, 3 17, 10-Q 9, DRS/A 8, UPLOAD 7, DRSLTR 6. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=NMRA (0.002 USD), /gw/filings/filings?ticker=NMRA&form=8-K, /gw/filings/facts?ticker=NMRA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange